{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:58:14Z","timestamp":1776128294248,"version":"3.50.1"},"reference-count":10,"publisher":"Centers for Disease Control MMWR Office","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6935a4","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:46:54Z","timestamp":1599144414000},"page":"1210-1215","source":"Crossref","is-referenced-by-count":74,"title":["Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment \u2014 United States, January\u2013June 2020"],"prefix":"10.15585","volume":"69","author":[{"given":"Lara","family":"Bull-Otterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth B.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Budnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather M.","family":"Strosnider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyna Z.","family":"Schieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macarena C.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Mac Kenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi V.","family":"Gundlapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R1","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R2","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State.","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R3","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. Rockville, MD: US Department of Health and Human Services, National Institutes of Health; 2020. https:\/\/www.covid19treatmentguidelines.nih.gov\/"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","article-title":"Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.","volume":"97","author":"Arshad","year":"2020","journal-title":"Int J Infect Dis"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019014","article-title":"Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19.","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2594","article-title":"US hydroxychloroquine, chloroquine, and azithromycin outpatient prescription trends, United States, October 2019\u2013March 2020.","author":"Shehab","year":"2020","journal-title":"JAMA Intern Med"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States.","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R8","unstructured":"Food and Drug Administration. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R9","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-020-00765-3","article-title":"Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence.","author":"Asensio","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"key-10.15585\/mmwr.mm6935a4-202009031046-R10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1177\/0961203396005001041","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.","volume":"5","author":"Furst","year":"1996","journal-title":"Lupus"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:47:07Z","timestamp":1599144427000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6935a4.htm?s_cid=mm6935a4_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":10,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2020,9,4]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6935a4","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,4]]},"published":{"date-parts":[[2020,9,4]]}}}